Hulst, L.; Cappuyns, S.; Peeters, F.; 119962; Vulsteke, F.; Van Herpe, F.; Van Cutsem, E.; Dekervel, J.; 87051;
BACKGROUND: About one third of patients with deficient mismatch repair/microsatellite instability-high metastatic colorectal cancer (dMMR/MSI-H mCRC) experience primary resistance or early progression on immune checkpoint inhibitors (ICI), while others benefit from exceptionally long-lasting responses. In this single-centre retrospective study, we ...
Li, Xiaojuan Kim, Jeehun Yang, Mingrui Ok, Ahmet Zbýň, Štefan Link, Thomas Majumdar, Sharmilar Ma, C Benjamin Spindler, Kurt Winalski, Carl
...
Articular cartilage damage and degeneration are among hallmark manifestations of joint injuries and arthritis, classically osteoarthritis. Cartilage compositional MRI (Cart-C MRI), a quantitative technique, which aims to detect early-stage cartilage matrix changes that precede macroscopic alterations, began development in the 1990s. However, despit...
Shiyanbola, Oyewale Nigdelioglu, Recep Dhall, Deepti González, Iván Warmke, Laura Schechter, Shula Choi, Won-Tak Hu, Shaomin Voltaggio, Lysandra Zhang, Yujie
...
Ewing sarcoma (ES) is an uncommon mesenchymal neoplasm that typically develops as a bone mass, although up to 30% arise in extraskeletal sites. ES of the gastrointestinal (GI) and hepatobiliary tract is rare and may be misdiagnosed as other, more common neoplasms that occur in these sites. However, the correct classification of extraskeletal ES is ...
Villamarín, Christian Loachamin, Melanie Sosa, Milton Donoso, Mishell Granda-Albuja, Genoveva Castillejo, Pablo Ríos-Touma, Blanca
Published in
Ecotoxicology (London, England)
Environmental impacts related to arsenic (As) contamination are a persistent issue of particular interest in Latin American countries with increasing mining activities. In Ecuador, the redefinition of public policies to promote the increase in mining since 2008 has led to a significant rise in the presence of this heavy metal in rivers and effluent...
Tongol, Elijah Kang, Preet Cheng, Vicki Gastonguay, Louise Beaudry, Felix E G Servidio-Italiano, Filomena De Vera, Mary A
Published in
BMC cancer
Molecular or biomarker testing to guide targeted treatments for colorectal cancer (CRC) has advanced care, specifically by improving treatment specificity. Our objective was to explore patients' experiences and perspectives with biomarker testing in Canada. We conducted a mixed-methods study among adults (≥ 18 years) who have been diagnosed with CR...
Saner, Flurina Takahashi, Kazuaki Budden, Timothy Pandey, Ahwan Ariyaratne, Dinuka Zwimpfer, Tibor Meagher, Nicola Fereday, Sian Twomey, Laura Pishas, Kathleen
...
PURPOSE: The purpose of this study was to evaluate RB1 expression and survival across ovarian carcinoma histotypes and how co-occurrence of BRCA1 or BRCA2 (BRCA) alterations and RB1 loss influences survival in tubo-ovarian high-grade serous carcinoma (HGSC). EXPERIMENTAL DESIGN: RB1 protein expression was classified by immunohistochemistry in ovari...
Meng, Qi Mitra, Sanjali Del Rosario, Irish Jerrett, Michael Janzen, Carla Devaskar, Sherin Ritz, Beate
BACKGROUND: Polycyclic aromatic hydrocarbons (PAHs) have been linked to adverse birth outcomes that have been reported to be induced by oxidative stress, but few epidemiological studies to date have evaluated associations between urinary PAH metabolites and oxidative stress biomarkers in pregnancy and identified critical periods for these outcomes ...
Claus, Jonas; De Smet, Dieter; Breyne, Joke; Wesolowski, Janusz; Himpe, Ulrike; Demedts, Ingel; 8424; Martens, Geert A.;
Cobas EGFR mutation Test v2 was FDA-approved as qualitative liquid biopsy for actionable EGFR variants in non-small cell lung cancer (NSCLC). It generates semiquantitative index (SQI) values that correlate with mutant allele levels, but decision thresholds for clinical use in NSCLC surveillance are lacking. We conducted long-term ctDNA monitoring i...
Zhu, Xiaolin Chan, Emily Turski, Michelle Mendez, Carlos Hsu, Sarah Kumar, Vipul Shipp, Chase Jindal, Tanya Chang, Kevin Onodera, Courtney
...
HER2, encoded by the ERBB2 gene, is an important druggable driver of human cancer gaining increasing importance as a therapeutic target in urothelial carcinoma (UC). The genomic underpinnings of HER2 overexpression in ERBB2 nonamplified UC are poorly defined. To address this knowledge gap, we investigated 172 UC tumors from patients treated at the ...
Shariff, Bushra Barnett, Reagan Dayyani, Farshid Maron, Steven Mcgriskin, Rory Klempner, Samuel Donderici, Elifnur Zhang, Nicole Masannat, Jude Drusbosky, Leylah
...
PURPOSE: In addition to the existing biomarkers HER2 and PD-L1, FGFR2b has become an area of interest for the development of new targeted-based treatment. Given that clinical evaluation of FGFR2 targeted therapy is underway, we sought to elucidate the genomic landscape of FGFR2amp in gastroesophageal cancer (GEC) using a circulating tumor DNA (ctDN...